avelumab|abdominal discomfort
avelumab|abdominal pain
avelumab|abdominal pain upper
avelumab|abortion
avelumab|acute kidney injury
avelumab|adrenal insufficiency
avelumab|anemia
avelumab|arthralgia
avelumab|arthritis
avelumab|asthenia
avelumab|back pain
avelumab|bullous dermatitis
avelumab|cellulitis
avelumab|cerebrovascular accident
avelumab|chills
avelumab|colitis
avelumab|constipation
avelumab|cough
avelumab|creatine kinase elevation
avelumab|creatinine increased
avelumab|cystitis
avelumab|death
avelumab|decreased appetite
avelumab|decreased weight
avelumab|dehydration
avelumab|demyelination
avelumab|dermatitis acneiform
avelumab|dermatitis bullous
avelumab|diabetic ketoacidosis
avelumab|diarrhea
avelumab|dizziness
avelumab|drug hypersensitivity
avelumab|dyspnea
avelumab|dyspnea exertional
avelumab|eczema
avelumab|embryo-fetal toxicity
avelumab|encephalitis
avelumab|endocrinopathies
avelumab|erythema
avelumab|erythema multiforme
avelumab|exertional dyspnea
avelumab|exfoliative dermatitis
avelumab|fatal
avelumab|fatigue
avelumab|fetal loss
avelumab|flushing
avelumab|gastrointestinal pain
avelumab|general disorders and administration site conditions
avelumab|generalized edema
avelumab|generalized pruritus
avelumab|ggt increased
avelumab|glomerular filtration rate decreased
avelumab|guillain-barr syndrome
avelumab|headache
avelumab|hematuria
avelumab|hemolytic anemia
avelumab|hepatitis
avelumab|histiocytic necrotizing lymphadenitis
avelumab|hyperglycemia
avelumab|hyperkalemia
avelumab|hypertension
avelumab|hypertensive crisis
avelumab|hyperthyroidism
avelumab|hyponatremia
avelumab|hypophagia
avelumab|hypophysitis
avelumab|hypopituitarism
avelumab|hypotension
avelumab|hypothyroidism
avelumab|ileus
avelumab|increased alanine aminotransferase
avelumab|increased alkaline phosphatase
avelumab|increased amylase
avelumab|increased aspartate aminotransferase
avelumab|increased bilirubin
avelumab|increased creatinine
avelumab|increased lipase
avelumab|infection
avelumab|infusion reaction
avelumab|infusion-related reaction
avelumab|infusion-related reactions
avelumab|intestinal obstruction
avelumab|iritis
avelumab|kidney infection
avelumab|lymphopenia
avelumab|malaise
avelumab|musculoskeletal pain
avelumab|myalgia
avelumab|myasthenia gravis
avelumab|myocarditis
avelumab|myositis
avelumab|nausea
avelumab|neck pain
avelumab|nephritis
avelumab|neutropenia
avelumab|pain in extremity
avelumab|pancreatitis
avelumab|pemphigoid
avelumab|pericardial effusion
avelumab|peripheral edema
avelumab|peripheral swelling
avelumab|pneumonitis
avelumab|productive cough
avelumab|pruritic rash
avelumab|pruritus
avelumab|pruritus generalized
avelumab|psoriasis
avelumab|pyrexia
avelumab|pyuria
avelumab|rash
avelumab|rash maculo-papular
avelumab|renal dysfunction
avelumab|renal failure
avelumab|respiratory failure
avelumab|retching
avelumab|rhabdomyolysis
avelumab|small intestine obstruction
avelumab|stevens johnson syndrome
avelumab|stillbirth
avelumab|systemic inflammatory response
avelumab|thrombocytopenia
avelumab|thyroiditis
avelumab|toxic epidermal necrolysis
avelumab|transaminitis
avelumab|tubulointerstitial nephritis
avelumab|type 1 diabetes mellitus
avelumab|urinary tract hemorrhage
avelumab|urinary tract infection
avelumab|urosepsis
avelumab|urticaria
avelumab|uveitis
avelumab|vasculitis
avelumab|vomiting
avelumab|weight decreased
avelumab|wheezing